The PLS-DA model that divided ALS patients into groups according to disease progression showed that the model to explain weight variation was at the limit of significance (pCV-ANOVA = 0.07; Supplementary Figure S2A ).
← all excerpts
Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis.
1
—
—